**Core Concept**
Acute myeloid leukemia (AML) is a heterogeneous group of malignancies characterized by the clonal expansion of myeloid blasts in the bone marrow, leading to impaired hematopoiesis. The classification of AML has evolved over the years, and the most recent World Health Organization (WHO) classification system recognizes eight distinct subtypes.

**Why the Correct Answer is Right**
The most common type of AML is Acute Myeloid Leukemia with Recurrent Genetic Abnormalities, specifically involving the cytoplasmic or nuclear expression of the M2 isoform of the CD117 antigen (CD117+). This subtype accounts for approximately 25-30% of all AML cases and is often associated with a normal karyotype. The pathogenesis of AML involves the accumulation of mutations in genes involved in cell cycle regulation, DNA repair, and signal transduction, leading to uncontrolled proliferation and differentiation arrest of myeloid progenitor cells.

**Why Each Wrong Option is Incorrect**
* **Option A:** Acute Promyelocytic Leukemia (APL) is a distinct subtype of AML, characterized by the presence of the PML-RARA fusion gene, which accounts for only 5-10% of all AML cases.
* **Option B:** Acute Megakaryoblastic Leukemia is a rare subtype of AML, accounting for less than 5% of all AML cases, and is often associated with a poor prognosis.
* **Option C:** Acute Erythroleukemia is another rare subtype of AML, accounting for less than 5% of all AML cases, and is often associated with a complex karyotype and a poor prognosis.

**Clinical Pearl / High-Yield Fact**
The most common genetic abnormality in AML is the internal tandem duplication (ITD) of the NPM1 gene, which occurs in approximately 30% of all AML cases. This mutation is often associated with a normal karyotype and a favorable prognosis.

**Correct Answer: C. Acute Myeloid Leukemia with Recurrent Genetic Abnormalities.**